On this page
Healthians posts FY26 profit as operating revenue rises 35.7% to Rs 357 crore
Our read
Healthians' first profitable year is likely to accelerate network-led growth and repeat preventive-care sales, but the durability of margin expansion will depend on whether it can grow collection density faster than competition raises acquisition and pricing pressure.
For operators
Healthians’ return to profitability alongside 35.7% revenue growth signals that its at-home diagnostics model is scaling efficiently, though its 99% reliance on diagnostics revenue underscores the need to deepen adjacent services.
Watch
Net-profit and EBITDA-margin progression, including whether profits remain positive after expansion spending.
The report,
Healthians became profitable in FY26, reporting Rs 5.4 crore net profit as operating revenue rose 35.7% to Rs 357 crore. The at-home diagnostics platform serves over 250 cities, while founder Deepak Sahni exited formal executive roles in January 2026.
Reported figures
From the report. Source details below
| Revenue from operations: | Rs 357 crore, up 35.7% YoY from Rs 263 crore |
|---|---|
| Total revenue: | Rs 362 crore versus Rs 270 crore |
| Net profit: | Rs 5.4 crore versus Rs 4.77 crore loss |
| Diagnostics revenue: | Rs 353 crore, 99% of operating revenue |
Also in the report
- At-home diagnostics available in 250+ cities; 10+ crore tests conducted
What to watch next
- FY27 revenue growth versus the FY26 35.7% rate.
- Diagnostics revenue concentration, which was 99% of operating revenue, and evidence of meaningful adjacent-service monetization.
- Order frequency, repeat-customer mix, average revenue per customer and subscription/package adoption.
- New city additions, sample-collection route density and turnaround-time performance.
The source
First seen